Section 14
Chapter 13,731

Human infant respiratory syncytial virus (RSV) -specific type 1 and 2 cytokine responses ex vivo during primary RSV infection

Lee, F.E.-H.; Walsh, E.E.; Falsey, A.R.; Lumb, M.E.; Okam, N.V.; Liu, N.; Divekar, A.A.; Hall, C.B.; Mosmann, T.R.

Journal of Infectious Diseases 195(12): 1779-1788


ISSN/ISBN: 0022-1899
PMID: 17492594
DOI: 10.1086/518249
Accession: 013730516

Respiratory syncytial virus (RSV) infection is the most common respiratory viral infection resulting in hospitalizations in infants worldwide. Illness severity is likely multifactorial; however, unlike other viral infections, both type 1 and type 2 cytokine responses have been implicated in severe disease. We measured RSV-specific cytokine responses ex vivo during primary RSV infection in the blood of 18 infants with polymerase chain reaction-confirmed RSV infection. To focus on primary RSV infection, subjects were all<9 months old. RSV-specific cytokine responses were measured at 3 time points during acute primary RSV infection and at 1 memory time point 3-6 months later. RSV-specific interferon (IFN)- gamma responses were detected in 10 of 18 of infants. Infants with mild disease had higher RSV-specific IFN- gamma memory responses than did those with moderate or severe disease. No consistent correlations between RSV-specific IFN- gamma responses and corticosteroid administration were observed. RSV-specific interleukin (IL)-4 or IL-5 responses to primary RSV infection were detectable in 5 of 18 and 8 of 15 infants, respectively. During primary RSV infection, many infants demonstrated RSV-specific IFN- gamma responses. The strongest IL-4 and IL-5 responses were detected in 3 infants with severe disease, suggesting that type 2 responses may contribute to the pathogenesis of severe disease.

PDF emailed within 0-6 h: $19.90